ClinicalTrials.Veeva

Menu

Insulin Sensitivity of the Brain in Pathogenesis of Diabetes Mellitus Type 2

U

University Hospital Tuebingen

Status

Unknown

Conditions

Human Physiology of Energy Homeostasis

Treatments

Drug: Saline
Drug: Human insulin

Study type

Interventional

Funder types

Other

Identifiers

NCT00638209
MEG-KFO-2
KFO-114
EudraCT 2006-004734-32

Details and patient eligibility

About

The purpose of the study is to investigate whether insulin sensitivity of the human brain correlates with insulin sensitivity of the liver.

Enrollment

42 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18-70 Risk factor(s) for type 2 diabetes (e.g. overweight, family history of diabetes)

Exclusion criteria

  • Type 2 diabetes pregnancy acute or chronic diseases

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

42 participants in 2 patient groups, including a placebo group

I
Active Comparator group
Treatment:
Drug: Human insulin
P
Placebo Comparator group
Treatment:
Drug: Saline

Trial contacts and locations

2

Loading...

Central trial contact

Andreas Fritsche, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems